'Core' Generics Leader Must Face Most AG Price-Fix Claims

A Connecticut federal judge ruled Wednesday that G&W Laboratories Inc. must face most price-fixing claims from dozens of state attorneys general targeting generic drugmakers, teeing the shuttered company up for trial...

Already a subscriber? Click here to view full article